BioPharm News

Apr 05, 2018
By BioPharm International Editors
The contract service provider will invest in a laboratory expansion at its site located in Tredegar, Wales, UK.
Apr 05, 2018
By BioPharm International Editors
The agency’s plan outlines its approach to implementing medical product programs and the use of financial resources.
Apr 05, 2018
By BioPharm International Editors
The active pharmaceutical ingredient and excipient provider has expanded its parenteral ingredient manufacturing capacity and lab services.
Apr 05, 2018
By BioPharm International Editors
Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.
Apr 05, 2018
By BioPharm International Editors
The contract development and manufacturing organization announced the addition of a new building complex that will house its headquarters in Bothell, WA.
Apr 05, 2018
By BioPharm International Editors
The European approval marks the first approval for a biosimilar in that region resulting from the companies’ joint portfolio.
Apr 05, 2018
By BioPharm International Editors
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
Apr 03, 2018
By BioPharm International Editors
Pfizer transfers CAR-T assets to Allogene Therapeutics under a new alliance to further develop immuno-oncology therapeutics.
Apr 03, 2018
By BioPharm International Editors
The agency has accepted AstraZeneca’s biologics license application for an investigational leukemia drug candidate and granted it priority review.
Apr 03, 2018
By BioPharm International Editors
The agency has release a report providing an overview of steps taken to enhance benefit-risk assessment in the review of drugs.
native1_300x100
lorem ipsum